Clinical trial
Effect of Interleukin-2 on HIV Treatment Interruption
NCT00015704
Study timeline
Registry last updated2021-11-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
HIV Infectionsunresolved
Interventions
AldesleukinDRUG · verified · RxNorm: aldesleukin
Sponsors & collaborators
Mapped research locations
New YorkNew York, United States3St LouisMissouri, United States2ClevelandOhio, United States2ChicagoIllinois, United States1Los AngelesCalifornia, United States1PittsburghPennsylvania, United States1DurhamNorth Carolina, United States1MinneapolisMinnesota, United States1OmahaNebraska, United States1Chapel HillNorth Carolina, United States1Palo AltoCalifornia, United States1San JoseCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00015704 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.